About the Hemoglobin Testing Market
The red blood cells in the bloodstream carry a protein known as hemoglobin, which helps to transport oxygen throughout the body. Hemoglobin tests are conducted to detect the quantity of hemoglobin present in the blood. These tests are often done as a part of complete blood count during a routine health check-up or at the time of any illness to determine the type of anemia, which occurs due to low count of red blood cells.
Studies estimated that worldwide around 416 million people were living with diabetes in 2015. Out of which, around 46% of them, i.e., 191.3 million people, were not diagnosed with this disease, owing to lack of awareness. Diabetes and anemia are not directly linked, but studies reveal that around 26% of people with diabetes are diagnosed with anemia. Kidney damage or chronic kidney disease is a common condition observed in people with chronic diabetes.
Technavio’s analysts forecast the global hemoglobin testing market to grow at a CAGR of 10.58% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global hemoglobin testing market for 2016-2020. To calculate the market size, we use revenue generated from the sales of various types of hemoglobin testing equipment and consumables.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Hemoglobin Testing Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the operating in this market.
Key vendors
• Abbott Diagnostics
• Alere
• Danaher
• EKF Diagnostics Holdings
• Roche Diagnostics
Other prominent vendors
• ACON Laboratories
• ARKRAY
• Bayer Medical Care
• Bio-Rad Laboratories
• Daiichi Biotech
• DiaSys Diagnostic Systems
• Diazyme Laboratories
• Epinex Diagnostics
• Erba Diagnostics
• Fisher Scientific
• GREEN CROSS MEDIS
• HORIBA
• HUMAN Gesellschaft für Biochemica und Diagnostica
• Masimo
• Mindray Medical International
• OrSense
• PTS Diagnostics
• Randox Laboratories
• Sebia
• Siemens Healthcare
• Sysmex
• TaiDoc Technology
• Tosoh Bioscience
• Trinity Biotech
• Una Health
Market driver
• Development and launch of novel hemoglobin testing devices
• For a full, detailed list, view our report
Market challenge
• High cost and maintenance of hemoglobin testing
• For a full, detailed list, view our report
Market trend
• Direct-to-consumer testing
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
• Invasive method
• Non-invasive method
PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 06: Market segmentation by product
• Global hemoglobin testing equipment market
• Global hemoglobin testing reagents and consumables market
PART 07: Market segmentation by technology
• Chromatography
• Immunoassay
• Other
PART 08: Market segmentation by end-user
• Laboratories
• Hospitals
• Research centers
PART 09: Geographical segmentation
• Hemoglobin testing market in Americas
• Reimbursement by Medicare in US
• Hemoglobin testing market in EMEA
• Hemoglobin testing market in APAC
PART 10: Market drivers
• Increasing incidence of diabetes and popularity of HbA1c tests
• Favorable reimbursement of hemoglobin testing
• Development and launch of novel hemoglobin testing devices
PART 11: Impact of drivers
PART 12: Market challenges
• High cost and maintenance of hemoglobin testing
• Stringent regulatory issues
• Threat of substitute products
PART 13: Impact of drivers and challenges
PART 14: Market trends
• Shift from centralized laboratory to POCT
• Increased mergers and acquisition (M&A)
• Direct-to-consumer testing
PART 15: Vendor landscape
• Competitive scenario
PART 16: Key vendor profiles
• Abbott Diagnostics
• Alere
• Danaher
• EKF Diagnostics Holdings
• Roche Diagnostics
• Other prominent vendors
PART 17: Appendix
• List of abbreviations
PART 18: Explore Technavio
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Types of hemoglobin testing methods
Exhibit 03: Global hemoglobin testing market 2015-2020 ($ billions)
Exhibit 04: Five forces analysis
Exhibit 05: Global hemoglobin testing market segmentation based on product
Exhibit 06: Global hemoglobin testing market segmentation based on product 2015
Exhibit 07: Global hemoglobin testing market segmentation based on product 2020
Exhibit 08: Global hemoglobin testing equipment market 2015
Exhibit 09: Global hemoglobin testing equipment market 2020
Exhibit 10: Global hemoglobin testing equipment market 2015-2020 ($ millions)
Exhibit 11: Global laboratory testing market 2015-2020 ($ millions)
Exhibit 12: Global POCT equipment market 2015-2020 ($ millions)
Exhibit 13: Global hemoglobin testing reagent and consumables market 2015-2020 ($ billions)
Exhibit 14: Segmentation of global hemoglobin testing market by product
Exhibit 15: Segmentation of global hemoglobin testing market by product ($ millions)
Exhibit 16: Segmentation of global hemoglobin testing market by technology 2015
Exhibit 17: Segmentation of global hemoglobin testing market by end-user 2015
Exhibit 18: Segmentation of global hemoglobin testing market by geography 2015
Exhibit 19: Segmentation of global hemoglobin testing market by geography 2020
Exhibit 20: Hemoglobinin testing market in Americas 2015-2020 ($ millions)
Exhibit 21: Selected laboratory service with national limitation amount (NLA) provided by Medicare
Exhibit 22: Estimation of few diseases in US
Exhibit 23: Hemoglobin testing market in EMEA 2015-2020 ($ millions)
Exhibit 24: Hemoglobin testing market in APAC 2015-2020 ($ millions)
Exhibit 25: Segmentation of global hemoglobin testing market by geography
Exhibit 26: Segmentation of global hemoglobin testing market by geography ($ millions)
Exhibit 27: Impact of drivers
Exhibit 28: Impact of drivers and challenges
Exhibit 29: Abbott Diagnostics: Key takeaways
Exhibit 30: Alere: Business segmentation by revenue 2014
Exhibit 31: Alere: Cardiometabolic division revenue and YoY growth rate 2012-2014 ($ millions)
Exhibit 32: Alere: Key takeaways
Exhibit 33: Danaher: Key takeaways
Exhibit 34: EKF Diagnostics: Business segmentation by revenue 2014
Exhibit 35: EKF Diagnostics: Business segmentation by revenue 2013 and 2014 ($ millions)
Exhibit 36: EKF Diagnostics Holdings: Key takeaways
Exhibit 37: Roche Diagnostics: Business segmentation by revenue 2015
Exhibit 38: Roche Diagnostics: Diabetes care - geographical segmentation by revenue 2015
Exhibit 39: Roche Diagnostics: Diabetes care - geographical segmentation by revenue 2014 and 2015 ($ millions)
Exhibit 40: Roche Diagnostics: Diabetes care - YoY revenue and growth rate ($ billions)
Exhibit 41: Roche Diagnostics: Key takeaways
